Literature DB >> 10792159

Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis.

J Leissner1, R Hohenfellner, J W Thüroff, H K Wolf.   

Abstract

OBJECTIVE: To determine the need to standardize the number and location of lymph nodes to be removed during radical cystectomy in patients with invasive bladder carcinoma. PATIENTS AND METHODS: The pelvic lymph nodes from 447 patients (mean age 62.8 years) who underwent radical cystectomy between 1986 and 1997 were evaluated. The number of lymph nodes was correlated with the depth of invasion of the primary tumour (pT), occurrence of nodal metastases, clinical outcome, the operating surgeons and the pathologists dissecting the nodes.
RESULTS: The clinical follow-up was available for 302 patients (mean follow-up 38.7 months). The mean (range) number of lymph nodes removed was 14.7 (1-46). The number of lymph nodes removed varied significantly among different surgeons but not among pathologists. In pT3 and pT4 tumours, a more extended lymphadenectomy (>/= 16 lymph nodes) correlated with a higher percentage of patients with documented nodal metastases. There was a significant correlation between the number of lymph nodes removed and the tumour-free 5-year survival in patients with pT1, pT2 or pT3 tumours, and in patients with 1-5 positive lymph nodes (P < 0.01).
CONCLUSION: Extensive lymphadenectomy significantly improves the prognosis of patients with invasive bladder cancer and represents a potentially curative procedure in patients with nodal metastases, including micrometastases that may escape detection during routine histopathological evaluation. The results indicate the need for a standardized lymph node dissection.

Entities:  

Mesh:

Year:  2000        PMID: 10792159     DOI: 10.1046/j.1464-410x.2000.00614.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  75 in total

Review 1.  [Standards and perspectives in diagnosis and therapy of bladder carcinoma].

Authors:  C Stief; D Zaak; M Stöckle; U Studer; R Knuechel; C Rödel; R Sauer; H Rubben
Journal:  Urologe A       Date:  2006-09       Impact factor: 0.639

Review 2.  Status of robotic cystectomy in 2005.

Authors:  Nicole L Miller; Dan Theodorescu
Journal:  World J Urol       Date:  2006-03-24       Impact factor: 4.226

Review 3.  [Extending the limits of lymphadenectomy during radical cystectomy: pitfalls in the interpretation of contemporary study results].

Authors:  H Suttmann; J Kamradt; F Becker; J Lehmann; M Stöckle
Journal:  Urologe A       Date:  2009-02       Impact factor: 0.639

4.  Bladder cancer: narrowing the gap between evidence and practice.

Authors:  Maha H A Hussain; David P Wood; Dean F Bajorin; Bernard H Bochner; Robert Dreicer; Donald L Lamm; Michael A O'Donnell; Arlene O Siefker-Radtke; Dan Theodorescu; Colin P Dinney
Journal:  J Clin Oncol       Date:  2009-10-26       Impact factor: 44.544

Review 5.  The role and extent of pelvic lymphadenectomy in the management of patients with invasive urothelial carcinoma.

Authors:  Seth P Lerner
Journal:  Curr Treat Options Oncol       Date:  2009-06-30

6.  The impact of lymph node status and features on oncological outcomes in urothelial carcinoma of the upper urinary tract (UTUC) treated by nephroureterectomy.

Authors:  Adil Ouzzane; Pierre Colin; Tarek P Ghoneim; Marc Zerbib; Alexandre De La Taille; François Audenet; Fabien Saint; Nicolas Hoarau; Emilie Adam; Marie Dominique Azemar; Henri Bensadoun; Luc Cormier; Olivier Cussenot; Alain Houlgatte; Gilles Karsenty; Charlotte Maurin; François Xavier Nouhaud; Véronique Phe; Thomas Polguer; Mathieu Roumiguié; Alain Ruffion; Morgan Rouprêt
Journal:  World J Urol       Date:  2012-12-11       Impact factor: 4.226

7.  Role of lymphadenectomy for invasive bladder cancer.

Authors:  Faysal A Yafi; Wassim Kassouf
Journal:  Can Urol Assoc J       Date:  2009-12       Impact factor: 1.862

8.  Extended lymph node dissection in patients with urothelial cell carcinoma of the bladder: can it make a difference?

Authors:  Magnus Holmer; Pär-Ola Bendahl; Thomas Davidsson; Sigurdur Gudjonsson; Wiking Månsson; Fredrik Liedberg
Journal:  World J Urol       Date:  2009-01-15       Impact factor: 4.226

Review 9.  Contemporary management of muscle-invasive bladder cancer.

Authors:  Marc A Dall'Era; Liang Cheng; Chong-Xian Pan
Journal:  Expert Rev Anticancer Ther       Date:  2012-07       Impact factor: 4.512

10.  Role of pelvic lymphadenectomy in the treatment of bladder cancer: a mini review.

Authors:  Ja Hyeon Ku
Journal:  Korean J Urol       Date:  2010-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.